The legislature is likely to pass a draft bill in the upcoming session allowing manufacturers of high-risk medical devices to receive tax reductions and government subsidies, Legislative Speaker Wang Jin-pyng (王金平) said yesterday.
“There is a consensus among legislators for such initiative, so we think it should not be a problem,” Wang said on the sidelines of a meeting for the review of biotechnology policies.
The bill would grant these companies tax reduction for their research and development expenditure and spending on personnel training, according to the government-funded Institute for Biotechnology and Medicine Industry, which proposed the bill to the government.
Furthermore, the bill will increase subsidies for local medical device makers to 25 percent of government subsidies for biotechnology industry from 8 percent, Wu Ming-fa (吳明發), chief executive officer of the biotech institute, said by telephone .
The bill would expand the coverage of the Act For The Development Of Biotech And New Pharmaceuticals Industry (生技新藥產業發展條例) to 56 percent of local medical device producers from 7 percent, the Chinese-language Commercial Times said.
The government on Saturday failed to meet the timetable it had set a year ago to include companies making Class 2 medical devices, such as disposable contact lenses, under the act.
The government promised on Aug. 31 last year to add 33 suggestions made by pharmaceutical companies into the act, and it will continue implementing these changes suggested by companies, Minister Without Portfolio Simon Chang (張善政) said at the meeting.
Meanwhile, biomedical group Microbio (中天) chairman Lu Kung-ming (路孔明) yesterday criticized the government for failing to reach an agreement with Chinese government to set up a unified standard for drug companies across the Taiwan Strait.
In response, Premier Jiang Yi-huah (江宜樺) said he had discussed the issue with the Mainland Affairs Council and Ministry of Health and Welfare, and would conduct further talks with the Chinese government.
Local vaccine maker Adimmune Corp (國光生技) chairman Steve Chan (詹啟賢) said a meeting between Taiwanese and Chinese companies and officials is to take place on Nov. 8 and Nov. 9 in China.
“The talk is likely to facilitate establishing a standard agreed by both sides concerning new drug applications, but it will still require both governments’ approvals for such a deal to be realized,” Chan said.
Contract chipmaker United Microelectronics Corp (UMC, 聯電) yesterday said it has signed a memorandum of understanding (MOU) with Polar Semiconductor LLC to collaborate on the production of 8-inch wafers in the US. The collaboration aims to strengthen 8-inch wafer manufacturing in the US amid Washington’s efforts to increase onshore manufacturing of semiconductors, contribute to supply chain resilience against shifting geopolitical dynamics, and ensure a secure domestic supply of power semiconductors critical to automotive, electric grids, robotic manufacturing and data centers, the companies said in a joint statement. Under the MOU, Polar and UMC will identify devices for Polar to manufacture at
TECH TITANS: Amazon’s latest chip joins Google in competing for the 90 percent market share held by Nvidia, which claims it is ‘a generation ahead of the industry’ Amazon Web Services (AWS) on Tuesday launched its in-house-built Trainium3 artificial intelligence (AI) chip, marking a significant push to compete with Nvidia Corp in the lucrative market for AI computing power. The move intensifies competition in the AI chip market, where Nvidia dominates with an estimated 80 to 90 percent market share for products used in training large language models that power the likes of ChatGPT. Google last week caused tremors in the industry when it was reported that Facebook-parent Meta Platforms Inc would employ Google AI chips in data centers, signaling new competition for Nvidia. This followed the release last month of
Two companies wholly owned by the daughter of the founder of Hon Hai Precision Industry Co (鴻海精密) on Monday reported to the Taiwan Stock Exchange that they would dispose of all of the Hon Hai shares they hold. In filings with the exchange, Hong Wei Investment Co (鋐維) said it would sell the 2.771 million Hon Hai shares it holds and Frontier Investment Corp (承鋒投資) said it would sell its 2.409 million Hon Hai shares from tomorrow until Jan. 3 next year. The two companies are wholly owned and chaired by Shirley Gou (郭曉玲), the eldest daughter of Hon Hai founder Terry
TARIFF TALKS: The US secretary of commerce is eyeing more than US$300 billion in investments and said Taiwan would train US workers, but Taipei has denied the latter US Secretary of Commerce Howard Lutnick said the US is expecting a large investment pledge from Taiwan in trade talks, while President William Lai (賴清德) listed areas that need improvement in order for projects to be completed. “We’re in the midst of discussions,” Lutnick said on Wednesday. “But the fact is, this administration’s goal is to bring semiconductor manufacturing to America.” Lai on Wednesday said Taiwan is supportive of US President Donald Trump’s goal of reindustrializing the US, including efforts to ramp up semiconductor production. Such a goal would require the US to reduce its reliance on Taiwan as a key source
RSS